&nbsp;

plansBodySurvivingCancer2.jpg

Aug 2018

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Document

2018 CSRT CoP Annual Report

Aug 2018

Regimen

CRBPPACL

Cancer Type:

Endocrine,

Thyroid

Intent: Palliative

Drugs Used:

PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph

May 2019

Regimen

ATEZ

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut)

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

DURV

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation

Drugs Used:

durvalumab

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

PRAL

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Palliative

Funding:

New Drug Funding Program

Pralatrexate - Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Drugs Used:

PRALAtrexate,

leucovorin

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

MEGETMXF

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative

Funding:

ODB - General Benefit

megestrol - oral tablets

ODB - General Benefit

tamoxifen

Drugs Used:

megestrol,

tamoxifen

Quick Link(s):

Regimen Monograph

May 2019

Regimen

MFOLFOX6

Cancer Type:

Gynecologic,

Ovary

Intent: Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2025

Document

obsb-locations-20-8-18.xml

Aug 2018

Document

obsb-locations-20-8-18.html

Aug 2018

Regimen

CISPGEMC

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant

Drugs Used:

gemcitabine,

CISplatin